BH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL | Cancer Research |  | 2017 | 543 | 1 | ||
| Revisiting IL-6 antagonism in multiple myeloma | Critical reviews in oncology/hematology | | 2016 | 492 | 0 | ||
| Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow | Leukemia |  | 2015 | 647 | 439 | ||
| Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow | Leukemia | | 2015 | 604 | 670 | ||
| Selective APRIL blockade delays systemic lupus erythematosus in mouse | PloS one | | 2012 | 619 | 299 | ||
| Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions | Rheumatology | | 2011 | 680 | 1 | ||
| Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow | Blood | | 2011 | 717 | 1 | ||
| Comment on "Cutting edge: FcR-like 6 is an MHC class II receptor" | The Journal of immunology | | 2010 | 584 | 0 | ||
| CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | | 2010 | 684 | 0 | ||
| Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | | 2009 | 666 | 0 | ||
| Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature" | The Journal of immunology | | 2009 | 544 | 0 | ||
| In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development | Histology and histopathology | 2009 | 638 | 0 | |||
| Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction | Trends in immunology | | 2009 | 578 | 0 | ||
| Synovial tissues concentrate secreted APRIL | Arthritis research & therapy | | 2009 | 669 | 392 | ||
| Heparan sulfate proteoglycans, Fc receptors, and DC suppression | Blood | | 2008 | 573 | 0 | ||
| Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas | European journal of cancer | | 2008 | 584 | 0 | ||
| Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells | Cancer research | | 2008 | 630 | 0 | ||
| APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells | Blood | | 2008 | 674 | 0 | ||
| Reconstitution of the immune system after hematopoietic stem cell transplantation in humans | Seminars in immunopathology | | 2008 | 579 | 890 | ||
| APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa | The Journal of clinical investigation | | 2008 | 675 | 774 | ||
| Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases | Experimental hematology | | 2008 | 619 | 0 | ||
| Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness | Blood | | 2007 | 225 | 273 | ||
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | | 2004 | 271 | 253 |
